# A Study of STAR-0215 in Healthy Adult Participants

> **NCT05477160** · PHASE1 · COMPLETED · sponsor: **Astria Therapeutics, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** STAR-0215 (SC)
- **DRUG:** Placebo (SC)
- **DRUG:** STAR-0215 (IV)
- **DRUG:** Placebo (IV)

## Key facts

- **NCT ID:** NCT05477160
- **Lead sponsor:** Astria Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-27
- **Primary completion:** 2023-11-17
- **Final completion:** 2023-11-17
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477160, "A Study of STAR-0215 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05477160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*